Schott AG, ARaymondlife and Vanrx Pharmasystems announce product compatibility for primary packaging of sterile injectables

02

SCHOTT AG and ARaymond Life are announcing that SCHOTT adaptiQ® vials and ARaymondlife RayDyLyo® plastic press-fit closures are confirmed as a Product Set for use with Vanrx Pharmasystems’ Aseptic Filling Work-cells. This Product Set is fully commercially available and ready-to-use (RTU), with closure integrity performance results available from the suppliers.

The compatibility testing was part of the Matrix Alliance, an industry initiative of leading packaging and component suppliers, which aims at providing pre-validated container/closure solutions to work on Vanrx’s Aseptic Filling Workcells.

Using this Product Set, pharmaceutical companies have the assurance that the combination will function as a high-performance primary packaging system for sterile injectables. Companies can move drug products to market faster, by establishing flexible manufacturing operations using pre-sterilized, nested ready-to-use vials and press-fit closures with integrated stoppers in combination with Vanrx’s robotic aseptic filling systems.

A specific advantage of RayDyLyo® plastic press-fit caps is that they stopper and seal containers in one step, replacing aluminum crimp caps and eliminating their particle risk.

In selecting a Product Set, pharmaceutical companies receive assurance that all elements of the set, vials and caps, have been proven for compatibility and machinability with Vanrx aseptic filling systems.

As of this date, Product Set combinations are available in ISO standard 6R, and 10R vials, and corresponding 20mm press-fit closures. Contacts to request samples and performance specifications are listed below. These products are certified to work with Vanrx’s Microcell Vial Filler and SA25 Aseptic Filling Workcell.

Speaking on behalf of the three companies, Vanrx’s vice president of marketing Greg Speakman said:

“All three of our companies have seen how pharmaceutical companies are shifting toward building flexible manufacturing operations. SCHOTT, ARaymondlife and Vanrx are helping bring new products to market faster, benefiting the patient and our customers’ ability to respond to uncertain market conditions.”

The testing leading to this product set was completed as part of the Matrix Alliance, a collaboration between leading pharmaceutical packaging companies, of which Vanrx, SCHOTT, and ARaymondlife are members. The Alliance was created because next-generation drugs require high-ly aligned manufacturing processes and packaging solutions.